Viewing Study NCT02137356

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2026-07-06 @ 2:27 AM
Study NCT ID: NCT02137356
Status: UNKNOWN
Last Update Posted: 2015-09-03
First Post: 2014-05-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal Cancer
Sponsor: Sheba Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rectal Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None rectal cancer View
None rectal adenocarcinoma View
None Selinexor View
None capecitabine View
None chemoradiation View
None radiation View
None radiotherapy View
None neoadjuvant View
None locally advanced rectal cancer View